Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about GamaMabs Raises €15M To Take Immune-activating Cancer Candidate Into The Clinic
Venture Capital

GamaMabs Raises €15M To Take Immune-activating Cancer Candidate Into The Clinic

by fiercebiotech.com posted 2years ago 5668 views
GamaMabs Pharma has raised €15 million ($16.4 million) to advance a monoclonal antibody against gynecological cancers into the clinic and up to proof-of-concept. Edmond de Rothschild Investment Partners' BioDiscovery 4 came on board to lead the Series B round.